Live from the NIH registry
Studies recruiting near Indio right now
Top 25 of 69 recruiting studies, sorted by proximity — each links to its official registry page
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Analog Device, Inc.
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
Phase 4
Interventional 30 participants sought
Samir Macwan, M.D., Inc. (S corporation) — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Comprehensive Cancer Center at Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Agendia
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype
Phase 2
Interventional 900 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Carotid Artery Calcification, Carotid Artery Diseases
N/A
Interventional 185 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Shockwave Medical, Inc.
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Obesity or Overweight
Phase 3
Interventional 300 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Amgen
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
Eisenhower Medical Center /ID# 233189 — Rancho Mirage, California (10.2 mi)
· Sponsor: AbbVie
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of Personalized Cancer Therapy to Determine Response and Toxicity
Cancer
N/A
Observational 10,000 participants sought
Eisenhower Medical Center, Lucy Curci Cancer Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Shu Mei Kato
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Palmtree Clinical Research — Palm Springs, California (19.0 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
Phase 3
Interventional 160 participants sought
Samir Macwan, M.D., Inc. (S corporation) — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Novo Nordisk A/S
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Palm Springs, CA — Palm Springs, California (19.0 mi)
· Sponsor: Mediar Therapeutics
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Phase 4
Interventional 1,335 participants sought
Desert Physicians Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Mayo Clinic
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 150 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
Desert Retina Consultants — Palm Desert, California (8.2 mi)
· Sponsor: ONL Therapeutics
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: National Cancer Institute (NCI)